OMC · Q3 2025 Earnings

Cautious

Omnicom Group

Reported October 21, 2025

30-second summary

Omnicom's Q3 organic growth slowed to 2.6% from 3.0% in Q2, with Media (+9.1%) again masking deterioration across nearly every other discipline — Experiential collapsed to -17.7%, Branding & Retail Commerce stayed at -16.9%, and PR worsened to -7.5%. The IPG close is now dated for late November with EU filing submitted October 20, and management is explicitly guiding to synergy upside beyond the original $750M. The real tell: management's tone pivoted from defensive (Q2) to forward-leaning on AI and integration, but the underlying portfolio ex-Media is shrinking.

Headline numbers

EPS

Q3 FY2025

$2.24

Revenue

Q3 FY2025

$4.04B

+4.0% YoY

Operating margin

Q3 FY2025

13.1%

Key financials

Q3 FY2025

Metric	Q3 FY2025	YoY	Q2 FY2025	QoQ
Revenue	$4.04B	+4.0%	$4.02B	+0.4%
EPS	$2.24	—	$2.05	+9.3%
Operating margin	13.1%	—	10.9%	+220bps

Guidance

Guidance broadly reaffirmed on organic growth, EBITDA margin, and tax rate; Q4 net interest expense quietly increased $2 million vs. prior Q4 estimate.

Guidance is issued for both next quarter and the full year. Both may appear below.

New guidance

Metric	Period	Guide	YoY
Foreign Exchange Translation Impact on Revenue	Q4 FY2025	Similar to Q3 (approximately 1.4% positive impact)	—
Net Interest Expense Increase	Q4 FY2025	Increase of approximately $7 million	—
Public Relations Organic Growth	Q4 FY2025	Similar declines expected as Q3 (Q3 decline: -7.5%)	—
Net Acquisitions Impact on Revenue	FY 2025	Not significant, excluding the IPG transaction	—

Reaffirmed unchanged this quarter: Organic Revenue Growth (Approximately 3% (in line with annual guidance)), Adjusted EBITDA Margin (10 basis points higher than full year 2024 results of 15.5%), Adjusted Income Tax Rate (between 26.5% and 27%), Share Repurchases (Close to $600 million)

Platform metrics

Q3 FY2025

Segment	Q3 FY2025
Organic Revenue Growth	2.6%

Profitability

Q3 FY2025

Segment	Q3 FY2025
EBITA Margin - Adjusted	16.1%
Operating Income Margin	13.1%
Salary and Related Costs as % of Revenue	44.0%

Management tone

Q4 2024 cautious macro → Q1 2025 IPG announcement framing → Q2 2025 defensive floor-protection → Q3 2025 forward-leaning on AI + synergy upside

The AI narrative escalated from "rollout" to "fastest growing platform in company history" in one quarter. Last quarter Paolo was conceding a 24–36 month ROI horizon and acknowledging that compute and storage costs hadn't yet hit client decision-making. This quarter the framing is: "It is now the fastest growing platform in our company's history." The shift from cost-realism to platform-leadership in 90 days is striking, and it's almost certainly designed to support the IPG synergy narrative ahead of close — but the underlying client-monetization data still hasn't been disclosed.

Synergy guidance moved from "deliver $750M" to "exceed $750M" without quantification. Across Q1 and Q2 management held the line at the originally announced $750M run-rate. This quarter: "we remain highly confident in exceeding the synergies we expected when we first announced the acquisition." In Q&A, Cahall pressed for the incremental number and management declined. This is the most material soft-disclosed change in the deal economics since announcement — and management is choosing to flag it without sizing it, which suggests the number is large enough to matter but they want to disclose it on their CES timeline.

Macro deflection of Q2 quietly disappeared. Last quarter John handed planning visibility to "Washington." This quarter that framing is gone, replaced by confidence in Q4 project work ($200–250M of typical opportunity cited in Q&A) and "no significant client losses or personnel departures" despite deal execution. The implicit message: the macro overhang that justified defensive guidance in July is no longer the binding constraint — execution and integration are.

Integration readiness language firmed materially. Q2: integration planning underway. Q3: "Our dedicated integration teams at both Omnicom and IPG have been working tirelessly to ensure we're ready to hit the ground running on day one." The OmniPlus operating system was introduced as the unified platform — a specific deliverable rather than a planning framework. EU filing on October 20 with late-November close timing puts hard dates against what was previously H2 directional guidance.

Segment weakness is being preemptively narrated rather than apologized for. Management volunteered the Q4 PR decline guide (-7.5% range) before being asked, attributing it to election comps. The Experiential -17.7% was framed as Olympics-cycling, not portfolio deterioration. This is expectation-management more than disclosure-improvement — investors should read it as fences being put up around the underperformers ahead of IPG close.

Recurring themes management leaned on this quarter:

Agentic AI acceleration and market leadershipIPG acquisition imminent close with synergy upsideOmniPlus platform as competitive differentiatorStrong new business momentum despite macro headwindsMargin expansion and operational efficiencyIntegration readiness and execution confidence

Risks management surfaced:

Macroeconomic uncertainty impacting creative project workEuropean market weakness and continental Europe decline of 3.1%Difficult comparisons in Q4 from prior year election and Olympics spendClient products coming off patent protection impacting healthcare disciplineBranding and retail commerce market conditions impacting new projects

Q&A highlights

Adam Berlin · UBS

Timeline for pro forma financials and guidance post-acquisition completion; detailed explanation of precision marketing deceleration, particularly in Europe and the Cordero consulting business.

Management indicated portfolio plans and synergies will be disclosed around CES (early January) with financial modeling guidance between then and year-end earnings. Precision marketing weakness was attributed to European government work declines in Cordero consulting business; rest of business described as very strong with good pipeline.

Acquisition completion expected by end of NovemberPortfolio plans disclosure targeted for week of CES (early January)Synergy P&L benefits expected to be confirmed for 2026Cordero (consulting) business saw particular year-over-year decline related to government work in major European countries

David Karnofsky · JP Morgan

Confirmation of organic growth expectations for full year; visibility on Q4 project work and client sentiment post-acquisition announcement; competitive position despite deal uncertainty.

Management confirmed comfort with original guidance range (2.5% to 4.5%). Highlighted Q4 project work opportunity of $200-250M. Noted that adjusting Q3 for Olympics and presidential election comparisons shows underlying ~4% organic growth. Emphasized no significant client losses or personnel departures despite deal execution.

Maintaining guidance of 2.5% to 4.5% organic growthQ4 typical project work availability: $200-250 million potentialQ3 adjusted organic growth (excluding Olympics/election) approximately 4%No significant client losses or personnel departures reported

Stephen Cahall · Wells Fargo

Creative business performance within media/advertising growth; impact of AI and generative AI on creative and media services; incremental synergies beyond previously disclosed targets.

Creative business characterized as stable; media driving the 9%+ organic growth. Paolo detailed extensive AI/generative AI integration across workflows including consumer research, creative concepting, production, journey planning, sports marketing, commerce, and health. Management indicated synergies in excess of original deal announcement targets but declined to disclose specific figures.

Media and advertising organic growth over 9%Creative business stable; growth coming from media sideAI agent framework integrated into automotive pitch process covering consumer research through customer journey planningSynergies identified in excess of original deal targets (specific numbers undisclosed)

Michael Nathanson · Moffett Nathanson

Revenue growth gap analysis between combined IPG/Omnicom entity versus Publicis and Aegis; specific growth opportunities to close competitive positioning.

Management declined to disclose detailed combined entity projections but noted that adjusting for Olympics/election impact in Q3 2023, underlying growth approximates Publicis's claimed 5% versus their 4%. Emphasized both companies healthy performers with sufficient market opportunity for continued growth. Focus on portfolio composition improvement post-merger.

Adjusted Q3 organic growth (excluding election/Olympics) approximately 4% versus Publicis's claimed 5%No material growth gap on normalized basisPortfolio composition improvement expected post-merger

Craig Huber · Huber Research

Three biggest revenue synergy opportunities from IPG/Omnicom combination; client sentiment and budget environment changes in past three months across U.S. and Europe.

Three primary synergy opportunities identified: (1) Media business scale-up from 50-60% larger combined entity with cost/speed improvements; (2) Healthcare portfolio leveraging combined talent and market-leading assets despite recent Pfizer loss; (3) Precision marketing recovery with visible improvement path for consulting segment. Client budgets remain intact; fourth quarter project funding approved pending confirmation.

Combined media business expected 50-60% larger than currentHealthcare portfolio described as punching above weight despite Pfizer lossPrecision marketing consulting segment with identified daylight on recoveryQ4 project funding already approved by clients; awaiting confirmation/execution

Answers to last quarter's watch list

IPG merger close in H2 2025 — EU filing submitted October 20 with late-November close expected. All other jurisdictions cleared. The deal is closing inside the H2 2025 window the company committed to in July.

Resolved positively

Branding & Retail Commerce trajectory — Stayed at -16.9% organic for a second consecutive quarter. The decline is no longer accelerating, but it's stuck at the trough with no recovery signal. Management did not call out a recovery path in Q&A.

Continue monitoring

Healthcare reversal — Improved from -4.9% to -1.9% organic, second consecutive negative quarter but trajectory is improving. Pfizer loss was acknowledged in Q&A as a known headwind; management framed the segment as "punching above weight." Not the thesis-breaker the Q2 trajectory threatened, but still not back to defensive contribution.

Continue monitoring

Media organic growth sustaining above mid-single-digits — Media accelerated to +9.1% from +8.2% in Q2, and was confirmed in Q&A as driving the entire portfolio's growth with creative described as "stable." The Media print is intact and the FY guide is supported on its back.

Resolved positively

Post-close buyback step-up — Not addressed this quarter. FY share repurchase guide of "close to $600M" remains capped by the merger agreement, with close now ~5 weeks out. The post-close buyback pace will be the first capital allocation signal of the combined entity.

Continue monitoring

AI-driven compensation model transition — No quantitative disclosure on outcomes-based contracts as a % of revenue or named clients. The narrative escalated (OmniPlus launch, "fastest growing platform"), but the monetization model evidence flagged in Q2 has not materialized in disclosure.

Not resolved

What to watch into next quarter

IPG close completion and Day-1 financial disclosure — late-November close means Q4 will be a partial-quarter combined entity. Watch for the specific close date, the opening balance sheet (particularly debt assumed and refinancing cadence), and whether the planned CES portfolio disclosure (week of January 5–9) actually quantifies the "exceeding $750M" synergy claim.

Precision Marketing recovery from +0.8% — management attributed the 420bps deceleration to Credera's European government work and said the rest of the segment is "very strong." Q4 organic above ~3% would validate the explanation; another sub-1% print would suggest broader weakness in the consulting franchise.

Q4 organic growth above 3% to defend the FY range midpoint — YTD organic is 3.0% and the FY guide range is 2.5–4.5%. With PR guided to a similar -7.5% Q4 decline and Experiential continuing to cycle Olympics comps, Q4 needs Media to hold +9% and Precision Marketing to recover for FY to land mid-range rather than lower-quartile.

Net interest expense run-rate — Q3-to-Q4 step up from +$5M to +$7M YoY drag is small in absolute terms but signals cash burn or borrowing pressure ahead of IPG debt assumption. Watch for the combined entity's pro forma interest expense disclosure at close.

Combined entity organic growth disclosure framework — management explicitly punted on pro forma metrics until CES. The disclosure choices made at that point (organic growth definition, segment reporting, synergy phasing) will set the multi-quarter narrative framework for the merged business.

Asia Pacific trajectory — APAC printed -3.7% organic, a region not flagged in management commentary. If APAC stays negative in Q4, it joins Europe (-3.1%) as a second materially negative region for the combined entity heading into 2026.

Sources

Omnicom Group Q3 2025 Earnings Release, filed with the SEC: https://www.sec.gov/Archives/edgar/data/29989/000002998925000035/a2025q3earningsrelease.htm
Omnicom Group Q3 2025 earnings call commentary (management remarks and Q&A)

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.